National Cancer Institute

Funding Opportunities

Sponsor Recent deadline Title Deadline 2 Deadline 3 FOA
National Cancer Institute (NCI) 2/8/2022 Cancer Target Discovery and Development (CTD2) (U01 Clinical Trial Not Allowed) 10/6/2022 PAR-21-274
National Cancer Institute (NCI) 1/25/2022 National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) 5/25/2022 9/25/2022 PAR-20-077
National Cancer Institute (NCI) 10/5/2022 National Cancer Institute’s Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) 2/5/2022 6/5/2022 PAR-21-033
National Cancer Institute (NCI) 2/22/2022 Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) PAR-19-325
National Cancer Institute (NCI) 9/25/2021 Notice of Special Interest (NOSI): Expanding Cancer Control Research in Persistent Poverty Areas 1/7/2022 –– NOT-CA-21-071
National Cancer Institute (NCI) 9/25/2021 Cancer Research Education Grants Program – Courses for Skills Development (R25 Clinical Trial Not Allowed) 5/25/2022 9/25/2022 PAR-21-278
National Cancer Institute (NCI) 9/25/2021 Cancer Research Education Grants Program – Research Experiences (R25 Clinical Trial Not Allowed) 5/25/2022 9/25/2022 PAR-21-279
National Cancer Institute (NCI) 9/27/2021 Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed) RFA-CA-21-050
National Cancer Institute (NCI) 9/27/2021 Coordinating Center for Canine Cancer Immunotherapy Network (K9CIN; U24 Clinical Trial Not Allowed) RFA-CA-21-051
National Cancer Institute (NCI) 9/29/2021 Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) RFA-CA-21-008

Can’t find what you’re looking for? Please contact Researchadmin@cancer.ufl.edu for assistance in finding additional funding opportunities.